- Home
- GLPG vs WERN Comparison
GLPG vs WERN Comparison
Compare GLPG & WERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- WERN
- Stock Information
- Founded
- GLPG 1999
- WERN 1956
- Country
- GLPG Belgium
- WERN United States
- Employees
- GLPG N/A
- WERN N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- WERN Trucking Freight/Courier Services
- Sector
- GLPG Health Care
- WERN Industrials
- Exchange
- GLPG Nasdaq
- WERN Nasdaq
- Market Cap
- GLPG 1.8B
- WERN 1.8B
- IPO Year
- GLPG 2005
- WERN N/A
- Fundamental
- Price
- GLPG $27.01
- WERN $24.00
- Analyst Decision
- GLPG Sell
- WERN Hold
- Analyst Count
- GLPG 4
- WERN 14
- Target Price
- GLPG $25.33
- WERN $34.57
- AVG Volume (30 Days)
- GLPG 438.7K
- WERN 1.0M
- Earning Date
- GLPG 04-23-2025
- WERN 04-29-2025
- Dividend Yield
- GLPG N/A
- WERN 2.01%
- EPS Growth
- GLPG N/A
- WERN N/A
- EPS
- GLPG N/A
- WERN 0.55
- Revenue
- GLPG $311,493,731.00
- WERN $3,030,258,000.00
- Revenue This Year
- GLPG $0.08
- WERN $3.79
- Revenue Next Year
- GLPG $0.23
- WERN $7.03
- P/E Ratio
- GLPG N/A
- WERN $50.84
- Revenue Growth
- GLPG 18.32
- WERN N/A
- 52 Week Low
- GLPG $22.36
- WERN $26.50
- 52 Week High
- GLPG $31.23
- WERN $42.48
- Technical
- Relative Strength Index (RSI)
- GLPG 64.82
- WERN 27.72
- Support Level
- GLPG $26.58
- WERN $27.48
- Resistance Level
- GLPG $27.50
- WERN $28.26
- Average True Range (ATR)
- GLPG 0.62
- WERN 1.05
- MACD
- GLPG 0.33
- WERN -0.14
- Stochastic Oscillator
- GLPG 80.76
- WERN 7.55
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.